FMP

FMP

Enter

RPRX - Royalty Pharma plc

Profile of Royalty Pharma plc(RPRX), Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in

photo-url-https://financialmodelingprep.com/image-stock/RPRX.png

Royalty Pharma plc

RPRX

NASDAQ

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

27.47 USD

0.3 (1.09%)

About

ceo

Mr. Pablo Gerardo Legorreta

sector

Healthcare

industry

Biotechnology

website

https://www.royaltypharma.com

exchange

NASDAQ

Description

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

CIK

0001802768

ISIN

GB00BMVP7Y09

CUSIP

G7709Q104

Address

110 East 59th Street

Phone

212 883 0200

Country

US

Employee

75

IPO Date

Jun 16, 2020

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep